tumorigenic

(redirected from tumorigenicity)
Also found in: Dictionary, Encyclopedia, Wikipedia.

tu·mor·i·gen·ic

(tū'mŏr-i-jen'ik),
Causing or producing tumors.

tumorigenic

(to͞o′mər-ə-jĕn′ĭk, tyo͞o′-)
adj.
Capable of causing tumors.

tu′mor·i·ge·nic′i·ty (-jə-nĭs′ĭ-tē) n.

tumorigenic

[-jen′ik]
Etymology: L, tumor, swelling; Gk, genein, to produce
capable of producing tumors.

tu·mor·i·gen·ic

(tū'mŏr-i-jen'ik)
Causing or producing tumors.
Synonym(s): tumourigenic.
References in periodicals archive ?
SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
Benvenisty, "The tumorigenicity of human embryonic stem cells," Advances in Cancer Research, vol.
Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma," Hepatology, vol.
These new tissue-, cell-, or gene therapy-based products will likely require additional testing such as immunogenicity, tumorigenicity, and biodistribution analyses to support product safety.
The potential for tumorigenicity makes BPyV contamination of bovine serum, biologicals seeds and other raw materials used for manufacture of veterinary and human products a cause for concern.
Adult stem cells per se display very few complications, while the major potential risk associated with pluripotent cells is tumorigenicity.
Since the transferred semi-allogeneic F1 NKT cells will be eliminated in a few days, this strategy reduces the intrinsic anxiety on tumorigenicity of iPS-derived cells in vivo.
Objective: "It is well documented that each human cancer has acquired a large number of mutations (50-500), some of which are drivers for tumorigenicity, others of which are indolent passengers.
Activator protein 2 alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells.
Chronic in vitro exposure to 3'-azido-2', 3'-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells.
Previous studies have reported that alterations in adult stem cells contributed to the enhancement of tumorigenicity (Strong et al.
Downregulation of miR-610 promotes proliferation and tumorigenicity and activates Wnt/[beta]-catenin signaling inhuman hepatocellular carcinoma.